Northern Trust Corp Vericel Corp Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

A detailed history of Northern Trust Corp transactions in Vericel Corp stock. As of the latest transaction made, Northern Trust Corp holds 511,330 shares of VCEL stock, worth $22.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
511,330
Previous 524,624 2.53%
Holding current value
$22.5 Million
Previous $27.3 Million 14.04%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$41.71 - $52.9 $554,492 - $703,252
-13,294 Reduced 2.53%
511,330 $23.5 Million
Q1 2024

May 14, 2024
SELL
$32.52 - $52.33 $484,027 - $778,879
-14,884 Reduced 2.76%
524,624 $27.3 Million
Q4 2023

Feb 13, 2024
SELL
$30.85 - $37.09 $371,804 - $447,008
-12,052 Reduced 2.19%
539,508 $19.2 Million
Q3 2023

Nov 13, 2023
BUY
$31.69 - $39.25 $69,591 - $86,193
2,196 Added 0.4%
551,560 $18.5 Million
Q2 2023

Aug 11, 2023
BUY
$29.0 - $38.37 $96,744 - $128,002
3,336 Added 0.61%
549,364 $20.6 Million
Q1 2023

May 15, 2023
BUY
$23.85 - $31.34 $129,863 - $170,646
5,445 Added 1.01%
546,028 $16 Million
Q4 2022

Feb 13, 2023
BUY
$17.65 - $27.37 $165,751 - $257,031
9,391 Added 1.77%
540,583 $14.2 Million
Q3 2022

Nov 14, 2022
BUY
$22.62 - $32.54 $120,474 - $173,308
5,326 Added 1.01%
531,192 $12.3 Million
Q2 2022

Aug 12, 2022
SELL
$22.88 - $39.45 $233,856 - $403,218
-10,221 Reduced 1.91%
525,866 $13.2 Million
Q1 2022

May 13, 2022
SELL
$31.69 - $43.29 $596,342 - $814,631
-18,818 Reduced 3.39%
536,087 $20.5 Million
Q4 2021

Feb 08, 2022
SELL
$35.2 - $52.6 $159,596 - $238,488
-4,534 Reduced 0.81%
554,905 $21.8 Million
Q3 2021

Nov 15, 2021
SELL
$46.35 - $59.75 $435,087 - $560,873
-9,387 Reduced 1.65%
559,439 $27.3 Million
Q2 2021

Aug 13, 2021
SELL
$47.2 - $67.81 $49,465 - $71,064
-1,048 Reduced 0.18%
568,826 $29.9 Million
Q1 2021

May 12, 2021
SELL
$30.93 - $59.48 $611,393 - $1.18 Million
-19,767 Reduced 3.35%
569,874 $31.7 Million
Q4 2020

Feb 11, 2021
SELL
$18.53 - $31.5 $285,121 - $484,690
-15,387 Reduced 2.54%
589,641 $18.2 Million
Q3 2020

Nov 16, 2020
SELL
$14.68 - $19.12 $367,367 - $478,478
-25,025 Reduced 3.97%
605,028 $11.2 Million
Q2 2020

Aug 14, 2020
BUY
$8.5 - $15.82 $353,319 - $657,589
41,567 Added 7.06%
630,053 $8.71 Million
Q1 2020

May 14, 2020
BUY
$7.25 - $19.22 $86,572 - $229,506
11,941 Added 2.07%
588,486 $5.4 Million
Q4 2019

Feb 14, 2020
SELL
$13.77 - $19.2 $75,583 - $105,388
-5,489 Reduced 0.94%
576,545 $10 Million
Q3 2019

Nov 13, 2019
BUY
$14.93 - $19.83 $287,626 - $382,024
19,265 Added 3.42%
582,034 $8.81 Million
Q2 2019

Aug 13, 2019
BUY
$15.01 - $18.89 $25,381 - $31,942
1,691 Added 0.3%
562,769 $10.6 Million
Q1 2019

May 13, 2019
BUY
$16.23 - $20.29 $175,754 - $219,720
10,829 Added 1.97%
561,078 $9.82 Million
Q4 2018

Feb 12, 2019
BUY
$10.77 - $18.44 $88,960 - $152,314
8,260 Added 1.52%
550,249 $9.58 Million
Q3 2018

Nov 14, 2018
BUY
$9.1 - $14.8 $995,967 - $1.62 Million
109,447 Added 25.3%
541,989 $7.67 Million
Q2 2018

Sep 18, 2018
BUY
$9.6 - $14.6 $2,515 - $3,825
262 Added 0.06%
432,542 $4.2 Million
Q2 2018

Aug 14, 2018
BUY
$9.6 - $14.6 $3.42 Million - $5.21 Million
356,752 Added 472.34%
432,280 $4.19 Million
Q1 2018

May 09, 2018
BUY
$5.7 - $12.3 $68,172 - $147,108
11,960 Added 18.81%
75,528 $751,000
Q4 2017

Feb 14, 2018
BUY
$3.65 - $5.98 $7,756 - $12,707
2,125 Added 3.46%
63,568 $346,000
Q3 2017

Nov 13, 2017
BUY
$3.0 - $6.0 $184,329 - $368,658
61,443
61,443 $369,000

Others Institutions Holding VCEL

# of Institutions
268
Shares Held
48.4M
Call Options Held
91.1K
Put Options Held
39.8K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.08B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email